This allergic reaction can be life threatening and can cause death, particularly if it is not treated as early as possible
Depletion of gut microbiota had no effect on the suppressed postprandial GIP levels in PAR2-G37I or PAR2-R38E mice when compared with PAR2-WT mice (Figure 1K)
Galderisi S, Mucci A, Dollfus S, Nordentoft M, Falkai P, et al
Summary Microdosing is typically treated as a tolerability-first, clinician-guided approach, involving starts below the usual 2.5 mg step, extending escalation windows from 4 to 8 weeks or more, or pausing at intermediate maintenance doses, such as 5 mg or 7.5 mg, to prioritize steady adherence and symptom control
self-pay adds flexibility